---
figid: PMC4229513__WJG-20-15467-g003
figlink: /pmc/articles/PMC4229513/figure/F3/
number: F3
caption: 'Outline of the targeted therapies, which are currently available or under
  development for the treatment of hepatocellular carcinoma, and the molecular targets
  on which they are believed to act upon. AKT: A protein kinase family of genes involved
  in regulation of cell survival, Bcl-2-associated agonist of cell death promoter
  (BAD), Bcl-2-associated death promoter; Disheveled (DSH) protein, downstream effector
  Disheveled; EGF: Epidermal growth factor; EGFR: EGF receptor; ERK: Extracellular
  signal-regulated kinase; Frizzled: A family of G-protein coupled receptor proteins
  that serve as receptors in the WNT/β-catenin signaling pathway; once activated:
  Frizzled leads to activation of Disheveled in the cytoplasm; GSK-3β: Glycogen synthase
  kinase 3β; HER2/neu: Human epidermal growth factor receptor 2, a cell membrane surface-bound
  receptor tyrosine kinase that is involved in the signal transduction pathways leading
  to cell growth and differentiation; MEK: Kinases that phosphorylate mitogen activated
  protein (MAP) kinase (MAPK); mTOR: Mammalian target of rapamycin; PDGFR: Platelet-derived
  growth factor receptor; PI3K: Phosphatidylinositol-3-kinase; PTEN: Phosphatase and
  tensin homolog, regulates cell-survival pathway; RAF: A MAP kinase kinase kinase
  (MAP3K) that functions in the MAPK/ERK signal transduction pathway; a serine/threonine-specific
  kinase; RAS: Prototypical member of the RAS superfamily of proteins; activation
  of RAS signaling causes cell growth, differentiation and survival; the dysregulation
  of RAS signaling can lead to oncogenesis and cancer.'
pmcid: PMC4229513
papertitle: 'Hepatitis C virus-mediated angiogenesis: Molecular mechanisms and therapeutic
  strategies.'
reftext: Mohamed Hassan, et al. World J Gastroenterol. 2014 Nov 14;20(42):15467-15475.
pmc_ranked_result_index: '74619'
pathway_score: 0.9634739
filename: WJG-20-15467-g003.jpg
figtitle: Outline of the targeted therapies, which are currently available or under
  development for the treatment of hepatocellular carcinoma, and the molecular targets
  on which they are believed to act upon
year: '2014'
organisms: Homo sapiens
ndex: 9dac0bba-debb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4229513__WJG-20-15467-g003.html
  '@type': Dataset
  description: 'Outline of the targeted therapies, which are currently available or
    under development for the treatment of hepatocellular carcinoma, and the molecular
    targets on which they are believed to act upon. AKT: A protein kinase family of
    genes involved in regulation of cell survival, Bcl-2-associated agonist of cell
    death promoter (BAD), Bcl-2-associated death promoter; Disheveled (DSH) protein,
    downstream effector Disheveled; EGF: Epidermal growth factor; EGFR: EGF receptor;
    ERK: Extracellular signal-regulated kinase; Frizzled: A family of G-protein coupled
    receptor proteins that serve as receptors in the WNT/β-catenin signaling pathway;
    once activated: Frizzled leads to activation of Disheveled in the cytoplasm; GSK-3β:
    Glycogen synthase kinase 3β; HER2/neu: Human epidermal growth factor receptor
    2, a cell membrane surface-bound receptor tyrosine kinase that is involved in
    the signal transduction pathways leading to cell growth and differentiation; MEK:
    Kinases that phosphorylate mitogen activated protein (MAP) kinase (MAPK); mTOR:
    Mammalian target of rapamycin; PDGFR: Platelet-derived growth factor receptor;
    PI3K: Phosphatidylinositol-3-kinase; PTEN: Phosphatase and tensin homolog, regulates
    cell-survival pathway; RAF: A MAP kinase kinase kinase (MAP3K) that functions
    in the MAPK/ERK signal transduction pathway; a serine/threonine-specific kinase;
    RAS: Prototypical member of the RAS superfamily of proteins; activation of RAS
    signaling causes cell growth, differentiation and survival; the dysregulation
    of RAS signaling can lead to oncogenesis and cancer.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT6
  - WNT4
  - WNT1
  - WNT5A
  - WNT8B
  - WNT10B
  - WNT8A
  - WNT16
  - WNT5B
  - WNT3A
  - FZD8
  - WNT7A
  - FZD2
  - FZD10
  - RAF1
  - WNT7B
  - WNT11
  - WNT2B
  - KDR
  - BAD
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CD
  - WNT2
  - WNT3
  - ARAF
  - IGF1R
  - BRAF
  - KRAS
  - NRAS
  - PIK3CB
  - PIK3R6
  - AKT2
  - AKT1
  - CTNNB1
  - EGFR
  - MAPK1
  - MAPK3
  - FZD9
  - PDGFRA
  - WNT9A
  - MAP2K1
  - MTOR
  - FZD6
  - FZD7
  - WNT9B
  - WNT10A
  - ERBB2
  - FZD1
  - PDGFRB
  - GSK3B
  - HRAS
  - PIK3R3
  - FZD4
  - MAP2K2
  - AKT3
  - FZD3
  - FLT4
  - PIK3CG
  - FLT1
  - FZD5
  - Cediranib
  - AZD6244
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: IGFR
  symbol: IGFR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: GSK3-B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
chemicals:
- word: Cediranib
  source: MESH
  identifier: C500926
- word: AZD6244
  source: MESH
  identifier: C517975
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4229513__F3
redirect_from: /figures/PMC4229513__F3
figtype: Figure
---
